PTGX
Protagonist Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$145.11
−2.48%Forward multiples
Based on analyst estimates
- P/E forward
- 72.44x
- P/E 2026E
- 31.21x
- P/E 2027E
- —
- P/E 2028E
- 74.48x
- P/S forward
- 25.80x
Trailing multiples
Trailing twelve months
- P/E TTM
- 119.13x
- PEG TTM
- 1.86x
- Price / book
- 11.16x
- Price / sales
- 33.30x
- Price / cash flow
- 71.57x
Enterprise value
- Enterprise value
- $8.6B
- EV / sales
- 30.56x
- EV / EBITDA
- 100.80x
- EV / EBIT
- 147.69x
- Market cap
- $9.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026